Further studies revealed that COVID-19 mRNA vaccination increases PD-L1 surface expression on peripheral blood granulocytes, monocytes, and intranodal or circulating T helper cells in both healthy and immunocompromised individuals [55,56]. This evidence concerns the gene CD274 and COVID-19.